Technology
Our People
Fred Schaufele, PhD
CEO and Director of Scientific Operations

Irina Krylova, PhD
Director of Environmental Studies

HaiGuang Zhang, PhD
Director of Technology

Mei Ling
Director of Consumer IT
Press Release
-
September 2022
XCellAssay announces renewal of its agreement for the right to negotiate an exclusive license with the UCSF Office of Innovation Ventures for the technology covered in US Patent #10,324,099 (Inventor, Dr. Fred Schaufele, co-Founder, XCellAssay). A prior freedom to operate analysis conducted with the Startup Legal Garage program of the University of California Hastings College of the Law indicated that no patents or patent applications were found at the time of the report that “appear to have issued claims or claims that are likely to issue that should be infringed by the XCA’s Product”.
-
March 2022
XCellAssay Co-Founder and CEO Fred Schaufele discusses our technology with the long-running Anti-Doping PodCast. The conversation focuses on lowering the high rates of abuse of anabolic steroids by amateur athletes, particularly youths, as performance enhancing drugs (PEDs). https://cleancompetition.org/2022/03/01/73-innovative-approaches-for-detecting-anabolic-androgenic-steroid-abuse-fred-schaufele-phd/
-
February 2020
XCellAssay announces the continuation of funding by the Partnership for Clean Competition (PCC) for the development of our technology for identifying persons exposed to known or unknown androgens or anabolic androgenic steroids. The PCC, which was founded by the U.S. Olympic & Paralympic Committee, the US Anti-Doping Agency, the National Football League and Major League Baseball, has awarded three research studies by Dr. Schaufele to develop the measurement capability as part of the PCC’s mission “to help generate the world’s most influential, effective and coveted methods and resources for detecting and deterring the use of performance enhancing substances by all athletes in all sports at all levels”.
-
May 2020
Abstracts of two XCellAssay studies, originally scheduled for presentation at the 2020 meeting of The Endocrine Society (cancelled due to the COVID-19 response), now are available at the Journal of the Endocrine Society:
https://academic.oup.com/jes/article/4/Supplement_1/SAT-748/5833501 and https://academic.oup.com/jes/article/4/Supplement_1/SUN-LB138/5832320